The competitive status of the US pharmaceutical industry: the influences of technology in determining international industrial competitive advantage
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | Undetermined |
| Veröffentlicht: |
Washington, DC
National Acad. Press
1983
|
| Schlagworte: | |
| Beschreibung: | X,102 S. graph. Darst. |
| ISBN: | 0309033969 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV006021315 | ||
| 003 | DE-604 | ||
| 005 | 19990715 | ||
| 007 | t | ||
| 008 | 921030s1983 d||| |||| 00||| und d | ||
| 020 | |a 0309033969 |9 0-309-03396-9 | ||
| 035 | |a (OCoLC)631457832 | ||
| 035 | |a (DE-599)BVBBV006021315 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-703 | ||
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 245 | 1 | 0 | |a The competitive status of the US pharmaceutical industry |b the influences of technology in determining international industrial competitive advantage |c Urheber: National Academy of Engineering <Washington, DC> / Pharmaceutical Panel. Hrsg. von Charles C. Edwards. Mitarb.: Lacy G. Thomas* |
| 264 | 1 | |a Washington, DC |b National Acad. Press |c 1983 | |
| 300 | |a X,102 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Internationaler Wettbewerb |0 (DE-588)4027415-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wettbewerb |0 (DE-588)4065835-1 |2 gnd |9 rswk-swf |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Wettbewerb |0 (DE-588)4065835-1 |D s |
| 689 | 0 | 2 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Internationaler Wettbewerb |0 (DE-588)4027415-9 |D s |
| 689 | 1 | 2 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Edwards, Charles C. |e Sonstige |4 oth | |
| 700 | 1 | |a Thomas, Lacy G. |e Sonstige |4 oth | |
| 710 | 2 | |a National Academy of Engineering |b Pharmaceutical Panel |e Sonstige |0 (DE-588)5549921-1 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003788242 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804120230419496960 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV006021315 |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)631457832 (DE-599)BVBBV006021315 |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01886nam a2200445 c 4500</leader><controlfield tag="001">BV006021315</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990715 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921030s1983 d||| |||| 00||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309033969</subfield><subfield code="9">0-309-03396-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)631457832</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006021315</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The competitive status of the US pharmaceutical industry</subfield><subfield code="b">the influences of technology in determining international industrial competitive advantage</subfield><subfield code="c">Urheber: National Academy of Engineering <Washington, DC> / Pharmaceutical Panel. Hrsg. von Charles C. Edwards. Mitarb.: Lacy G. Thomas*</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Acad. Press</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X,102 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Internationaler Wettbewerb</subfield><subfield code="0">(DE-588)4027415-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wettbewerb</subfield><subfield code="0">(DE-588)4065835-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wettbewerb</subfield><subfield code="0">(DE-588)4065835-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Internationaler Wettbewerb</subfield><subfield code="0">(DE-588)4027415-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Edwards, Charles C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomas, Lacy G.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Academy of Engineering</subfield><subfield code="b">Pharmaceutical Panel</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5549921-1</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003788242</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| geographic | USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV006021315 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:38:47Z |
| institution | BVB |
| institution_GND | (DE-588)5549921-1 |
| isbn | 0309033969 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003788242 |
| oclc_num | 631457832 |
| open_access_boolean | |
| owner | DE-703 |
| owner_facet | DE-703 |
| physical | X,102 S. graph. Darst. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | National Acad. Press |
| record_format | marc |
| spelling | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage Urheber: National Academy of Engineering <Washington, DC> / Pharmaceutical Panel. Hrsg. von Charles C. Edwards. Mitarb.: Lacy G. Thomas* Washington, DC National Acad. Press 1983 X,102 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Internationaler Wettbewerb (DE-588)4027415-9 gnd rswk-swf Wettbewerb (DE-588)4065835-1 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Wettbewerb (DE-588)4065835-1 s Pharmazeutische Industrie (DE-588)4045696-1 s DE-604 Internationaler Wettbewerb (DE-588)4027415-9 s 1\p DE-604 Edwards, Charles C. Sonstige oth Thomas, Lacy G. Sonstige oth National Academy of Engineering Pharmaceutical Panel Sonstige (DE-588)5549921-1 oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage Pharmazeutische Industrie (DE-588)4045696-1 gnd Internationaler Wettbewerb (DE-588)4027415-9 gnd Wettbewerb (DE-588)4065835-1 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4027415-9 (DE-588)4065835-1 (DE-588)4078704-7 |
| title | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage |
| title_auth | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage |
| title_exact_search | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage |
| title_full | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage Urheber: National Academy of Engineering <Washington, DC> / Pharmaceutical Panel. Hrsg. von Charles C. Edwards. Mitarb.: Lacy G. Thomas* |
| title_fullStr | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage Urheber: National Academy of Engineering <Washington, DC> / Pharmaceutical Panel. Hrsg. von Charles C. Edwards. Mitarb.: Lacy G. Thomas* |
| title_full_unstemmed | The competitive status of the US pharmaceutical industry the influences of technology in determining international industrial competitive advantage Urheber: National Academy of Engineering <Washington, DC> / Pharmaceutical Panel. Hrsg. von Charles C. Edwards. Mitarb.: Lacy G. Thomas* |
| title_short | The competitive status of the US pharmaceutical industry |
| title_sort | the competitive status of the us pharmaceutical industry the influences of technology in determining international industrial competitive advantage |
| title_sub | the influences of technology in determining international industrial competitive advantage |
| topic | Pharmazeutische Industrie (DE-588)4045696-1 gnd Internationaler Wettbewerb (DE-588)4027415-9 gnd Wettbewerb (DE-588)4065835-1 gnd |
| topic_facet | Pharmazeutische Industrie Internationaler Wettbewerb Wettbewerb USA |
| work_keys_str_mv | AT edwardscharlesc thecompetitivestatusoftheuspharmaceuticalindustrytheinfluencesoftechnologyindetermininginternationalindustrialcompetitiveadvantage AT thomaslacyg thecompetitivestatusoftheuspharmaceuticalindustrytheinfluencesoftechnologyindetermininginternationalindustrialcompetitiveadvantage AT nationalacademyofengineeringpharmaceuticalpanel thecompetitivestatusoftheuspharmaceuticalindustrytheinfluencesoftechnologyindetermininginternationalindustrialcompetitiveadvantage |